Zoon Kathryn C's Form 4 filing
Emergent BioSolutions Inc.EBS · filed Jul 24, 2023
- Accession no.
- 0001367644-23-000137
- Filed
- Jul 24, 2023
- Trade date
- May 25-Jun 2, 2023
- Filing delay
- 60 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $29.5K. It was filed 60 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zoon Kathryn CCIK 0001685720 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 25, 2023 | Common Stock | SSaleDisposed | −1,700 | $8.38 | −$14,246 | 51,801 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −1,830 | $8.35 | −$15,280.5 | 49,971 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in it's next proxy statement.